Follicum Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
Follicum General Information
Description
Operator of a biotechnology company focused on developing drugs based on peptides derived from human proteins to stimulate hair growth. The company offers derma cosmetic products and pioneering drugs for the treatment of diabetes complications and cancer.
Contact Information
Website
www.follicum.comCorporate Office
- Scheelevägen 22
- 223 63 Lund
- Sweden
Corporate Office
- Scheelevägen 22
- 223 63 Lund
- Sweden
Follicum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 07-Feb-2022 | Completed | Generating Revenue | |||
| 6. PIPE | 22-Jan-2018 | Completed | Generating Revenue | |||
| 5. IPO | 25-Nov-2014 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Jan-2014 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2013 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 11-Dec-2012 | $710K | $1.15M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Jan-2011 | $438K | $438K | Completed | Generating Revenue |
Follicum Patents
Follicum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021369462-A1 | Peptides for use in skin and hair pigmentation | Pending | 28-Oct-2020 | ||
| CA-3196679-A1 | Peptides for use in skin and hair pigmentation | Pending | 28-Oct-2020 | ||
| EP-4236981-A1 | Peptides for use in skin and hair pigmentation | Pending | 28-Oct-2020 | ||
| US-12760067-B2 | Peptides for use in skin and hair pigmentation | Active | 28-Oct-2020 | ||
| US-20240228536-A1 | Peptides for use in skin and hair pigmentation | Active | 28-Oct-2020 | C07K5/101 |
Follicum Signals
Follicum Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Almi Invest | Venture Capital | Minority | ||
| Lund University Bioscience | Venture Capital | Minority | ||
| Sunstone Life Science Ventures | Venture Capital | Minority | ||
| Swedish Growth Fund | Venture Capital | Minority | ||
| Vinnova | Government | Minority |
Follicum ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Follicum FAQs
-
When was Follicum founded?
Follicum was founded in 2011.
-
Where is Follicum headquartered?
Follicum is headquartered in Lund, Sweden.
-
What is the size of Follicum?
Follicum has 4 total employees.
-
What industry is Follicum in?
Follicum’s primary industry is Drug Discovery.
-
Is Follicum a private or public company?
Follicum is a Private company.
-
What is Follicum’s current revenue?
The current revenue for Follicum is .
-
How much funding has Follicum raised over time?
Follicum has raised $1.16M.
-
Who are Follicum’s investors?
Almi Invest, Lund University Bioscience, Sunstone Life Science Ventures, Swedish Growth Fund, and Vinnova have invested in Follicum.
-
When was Follicum acquired?
Follicum was acquired on 07-Feb-2022.
-
Who acquired Follicum?
Follicum was acquired by Coegin Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process